Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Catalyst Pharma (CPRX – Research Report), ...

Investing.com — 周一，Stifel分析师维持对Avanos Medical（NYSE:AVNS）股票的持有评级，目标价为17.00美元。该股目前交易价格为12.43美元，接近其52周低点11.90美元，过去六个月下跌了45.65%。根据InvestingPro分析，基于其综合公允价值模型，该公司目前被低估。 Avanos Medical是 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

On Monday, Stifel analysts maintained a Hold rating on Avanos Medical (NYSE:AVNS) shares, with a set price target of $17.00. The... Avanos Medical, Inc. (NYSE:AVNS), a leading provider of medical ...

Investing.com — Avanos Medical, Inc. (NYSE:AVNS)，一家市值5.72亿美元的领先医疗设备和用品供应商，宣布其高管团队发生重大变动，包括前临时首席执行官Michael C. Greiner的离职。该公告于今日发布，此前该公司本月早些时候已开始一系列高管过渡。该公司股票面临重大 ...

If administered early, gene therapy has the potential to change the medical history of children born with metachromatic leukodystrophy (MLD), a rare and lethal neurodegenerative disease of genetic ...